Moreover, increased ADAT2 mRNA level is associated with poor prognosis in breast cancer patients and ADAT protein levels were found by immunohistochemistry staining to be higher in BRCA1 mutant compared with BRCA1 wild-type breast tumors [25,26]. This evidence concerns the gene ADAT2 and breast cancer.